The groundbreaking therapy of this peptide represents a exciting breakthrough in the care of the condition. Different to existing therapies, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide091652.imblogs.net/91888267/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment